Skip to content
S1776Senate2021-2022 SessionSame asA344

Restrict Tianeptine Sodium Use

Official title

“Adds tianeptine sodium to the list of Schedule II of controlled substances”

Sponsor James SkoufisSD-39Affects Health
Status
In Senate Committee
Health
Impact
4/10
Low
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill adds tianeptine sodium to New York's Schedule II controlled substances list.

Why it matters

  1. Tianeptine sodium would become subject to stricter controls. Scheduling it as a Schedule II substance means it would be regulated similarly to drugs with high potential for abuse, such as oxycodone or methadone, affecting its legal availability and how it can be prescribed or dispensed.

  2. Potential reduction in misuse and abuse. Tianeptine, sometimes referred to as "gas station heroin," has been associated with addiction and serious health risks. This change could help curb its abuse and related public health issues within New York State.

  3. Impact on consumers and healthcare providers. Any legitimate use of tianeptine sodium (such as for research or off-label therapeutic purposes) would now require compliance with stricter prescribing, record-keeping, and security requirements, potentially limiting access for patients and institutions.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Sellers and distributors of tianeptine sodium

    The bill would place the substance in Schedule II of New York’s controlled substances law.

  • People who possess or use tianeptine sodium

    The bill would classify the substance they possess or use as a Schedule II controlled substance.

  • State health regulators and law enforcement agencies

    The bill would add tianeptine sodium to the controlled substances schedule they administer or enforce, effective 90 days after becoming law.

Headline styles

Restrict Tianeptine Sodium Use

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
James Skoufis

Senator · Senate District 39

Chair, Investigations And Government Operations

No co-sponsors yet.

History

  1. Referred to health
  2. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A344Assembly

Ban Tianeptine Sodium Sales

In Assembly Committee · Health · Sponsor Edward Braunstein

Impact 4 · Low0% to pass

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

1776

2021-2022 Regular Sessions

IN SENATE

January 15, 2021

Introduced by Sen. SKOUFIS -- read twice and ordered printed, and when printed to be committed to the Committee on Health

AN ACT to amend the public health law, in relation to adding tianeptine sodium to schedule II of controlled substances

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subdivision (e) of schedule II of section 3306 of the public health law is amended by adding a new paragraph 5 to read as follows:

(5) Tianeptine sodium.

§ 2. This act shall take effect on the ninetieth day after it shall have become a law.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD03419-01-1

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the public health law, in relation to adding tianeptine sodium to schedule II of controlled substances

Purpose

Adds tianeptine sodium to the list of schedule II of controlled substances SUMMARY OF PROVISIONS:

Section 1. Subdivision (e) of schedule II of Section 3306 of the Public Health Law is amended by adding a new paragraph 5.

Section 2 sets forth the effective date.

Difference between original and amended version (if applicable)

n/a

Justification

Tianeptine sodium is an antidepressant that has not been approved by the United States Food and Drug Administration. It has also not been approved for medical use in Australia, Canada and the United Kingdom. However, it is still available for purchase online and is marketed as a supplement or research chemical. Tianeptine sodium is often abused in high doses to simulate opioid like highs and can lead to addiction coupled with withdrawal symptoms.

According to the Associated Press, Michigan became the first state to ban tianeptine sodium "after a spate of gruesome overdoses related to tianeptine sodium scoured the Midland and Saginaw area in 2017." Addi- tionally, the U.S. Centers for Disease Control and Prevention's Morbi- di-ty and Mortality Weekly Report in August, 2018, reported there were 207 poison control center calls related to tianeptine sodium from 2014- 2018, compared to only 11 calls in the previous 14 years.

The Associated Press reported that a substance abuse recovery coach testified before the Michigan State Senate about how her "addiction to tianeptine sodium affected her while weaning herself off heroin a proc- ess she said was far less horrific than tianeptine withdrawal. I could not get out of bed, go to work, have a normal functioning day without (tianeptine sodium) in my life. I am convinced that (it) is the next epidemic."

Legislative history

2020 - S8023 Referred to Health

Assembly

2020 - A7750 Referred to Health

Fiscal implications

None

Effective date

This act shall take effect on the ninetieth day after it shall become law.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.